Published in Int J Impot Res on October 29, 2015
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol (2010) 8.93
Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med (2013) 7.95
Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat (2013) 7.11
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst (2009) 6.07
Impotence following radical prostatectomy: insight into etiology and prevention. J Urol (1982) 4.08
Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol (2008) 3.50
Factors determining functional outcomes after radical prostatectomy: robot-assisted versus retropubic. Eur Urol (2011) 3.05
Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol (2010) 2.89
Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol (2012) 2.43
Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med (2010) 2.17
Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int (2008) 2.12
Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol (2011) 2.12
Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res (2008) 2.00
Vattikuti Institute prostatectomy: technique. J Urol (2003) 1.91
The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. J Sex Med (2008) 1.88
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol (1994) 1.87
Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon. BJU Int (2010) 1.68
Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol (1991) 1.63
The psychological impact of a cancer diagnosis on families: the influence of family functioning and patients' illness characteristics on depression and anxiety. Psychooncology (2004) 1.47
Alcohol consumption and male erectile dysfunction: an unfounded reputation for risk? J Sex Med (2009) 1.46
Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol (2008) 1.30
Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res (2007) 1.30
Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int (2007) 1.27
Changing trends of prostate cancer in Asia. Aging Male (2004) 1.24
Erectile function recovery rate after radical prostatectomy: a meta-analysis. J Sex Med (2009) 1.19
Direct comparison of surgical and functional outcomes of robotic-assisted versus pure laparoscopic radical prostatectomy: single-surgeon experience. Urology (2008) 1.12
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer. BJU Int (2008) 1.11
Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification. J Sex Med (2010) 1.07
Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs (2006) 0.99
Robot-assisted laparoscopic radical prostatectomy in the Asian population: modified port configuration and ultradissection. Int J Urol (2010) 0.96
Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology (1998) 0.96
Role of Viagra after radical prostatectomy. Urology (2000) 0.95
Management of erectile dysfunction after radical prostatectomy in 2007. World J Urol (2007) 0.92
Penile rehabilitation following radical prostatectomy: predicting success. J Sex Med (2009) 0.91
Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction. Br J Clin Pharmacol (2009) 0.87
Remembered International Index of Erectile Function domain scores are not accurate in assessing preoperative potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. J Sex Med (2008) 0.85
Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev (2013) 0.84
The effect of alcohol drinking on erectile dysfunction in Chinese men. Int J Impot Res (2010) 0.83
Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol (2006) 0.82
Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy. J Endourol (2013) 0.81
Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology (2004) 0.81
Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction. J Urol (2000) 0.80
Predictive factors for return of erectile function in robotic radical prostatectomy: case series from a single centre. Int J Impot Res (2014) 0.78
Udenafil enhances the recovery of erectile function and ameliorates the pathophysiological consequences of cavernous nerve resection. J Sex Med (2010) 0.78
Impacting factors for recovery of erectile function within 1 year following robotic-assisted laparoscopic radical prostatectomy. J Sex Med (2011) 0.76